Cases – Page 3 – ClaimsFiler

Recent Security Class Actions

On January 31, 2025, Newmont Corporation was sued for violations of the federal securities laws in the United States District Court for the District of Colorado on behalf of investors who purchased or otherwise acquired Newmont securities between February 22, 2024 and October 23, 2024, inclusive (the “Class Period”).

On January 30, 2025, TELUS International (Cda) Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise
acquired Telus International securities between February 16, 2023 and August 1, 2024, inclusive (the “Class Period”).

On January 30, 2025, Walgreens Boots Alliance, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of Illinois on behalf of investors who purchased or otherwise acquired Walgreens common stock between April 2, 2020 and January 16, 2025, both dates inclusive (the “Class Period”).

On January 30, 2025, Polestar Automotive Holding UK PLC was sued for violations of the federal securities laws in the United States District Court for the District of New Jersey on behalf of investors who purchased or otherwise acquired publicly traded securities between November 14, 2022 and January 16, 2025, both dates inclusive (the “Class Period”).

On January 30, 2025, Grocery Outlet Holding Corp. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or
otherwise acquired Grocery Outlet securities between November 7, 2023, to May 7, 2024, inclusive (the “Class Period”).

On January 29, 2025, Arconic Corporation was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who sold publicly
traded shares of Arconic common stock between April 19, 2022 and May 3, 2023, both dates inclusive (the “Class Period”).

On January 29, 2025, Integral Ad Science Holding Corp. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased
shares of IAS common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”).

On January 29, 2025, ModivCare, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Colorado on behalf of investors who purchased or otherwise
acquired ModivCare securities between November 3, 2022, and September 15, 2024, inclusive (the “Class Period”).

On January 24, 2025, ESSA Pharma Inc. was sued for violations of the federal securities laws in the  United States District Court for the District of Wisconsin on behalf of investors who purchased or otherwise acquired ESSA securities between December 12, 2023 and October 31, 2024, both dates inclusive (the “Class Period”).

On January 24, 2025, Novo Nordisk A/S was sued for violations of the federal securities laws in the  United States District Court for the District of New Jersey on behalf of investors who purchased or otherwise acquired Novo securities between November 2, 2022 to December 19, 2024, inclusive (the “Class Period”).

On January 22, 2025, Crocs, Inc. was sued for violations of the federal securities laws in the  United States District Court for the District of Delaware on behalf of investors who purchased or otherwise acquired Crocs common stock between November 3, 2022, and October, 28 2024, inclusive (the “Class Period”).

On January 22, 2025, Cardlytics, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of Georgia on behalf of investors who purchased the Company’s shares between March 14, 2024 and August 7, 2024, inclusive (the “Class Period”).

On January 17, 2025, Innovative Industrial Properties, Inc. was sued for violations of the federal securities laws in the  United States District Court for the District of Maryland on behalf of investors who purchased or otherwise acquired IIPR securities between February 27, 2024 and December 19, 2024, both dates inclusive (the “Class Period”).

On January 17, 2025, Block, Inc. was sued for violations of the federal securities laws in the  United States District Court for the Northern District of California on behalf of all purchasers of Block Class A common stock between February 26, 2020 and April 30, 2024, inclusive (“Class Period”).

On January 17, 2025, FTAI Aviation Ltd. was sued for violations of the federal securities laws in the  United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise
acquired FTAI securities between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”).

On January 13, 2025, Pacira Biosciences, Inc. was sued for violations of the federal securities laws in the  United States District Court for the District of New Jersey on behalf of investors who purchased or otherwise acquired Pacira securities between August 2, 2023 to August 8, 2024, inclusive (the “Class Period”).

On January 9, 2025, Micron Technology, Inc. was sued for violations of the federal securities laws in the  United States District Court for the Southern District of Florida on behalf of investors who purchased or otherwise acquired Micron common stock between September 28, 2023 and December 18, 2024, both dates inclusive (the “Class Period”).

On January 7, 2025, Regeneron Pharmaceuticals, Inc. was sued for violations of the federal securities laws in the  United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise
acquired Regeneron securities between November 2, 2023 and October 30, 2024, inclusive (the “Class Period”).

On January 7, 2025, BioAge Labs, Inc. was sued for violations of the federal securities laws in the  United States District Court for the Northern District of California on behalf of investors who purchased stock pursuant and/or traceable to BioAge’s registration statement for the initial public offering held on or about September 26, 2024.

On January 3, 2025, Revance Therapeutics, Inc. was sued for violations of the federal securities laws in the  United States District Court for the Middle District of Tennessee on behalf of investors who purchased or otherwise acquired Revance securities between February 29, 2024 and December 6, 2024, both dates inclusive (the “Class Period”).

We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.

OK